P16 Positive Squamous Cell Carcinoma of the Vagina or Vulva Recruiting Phase 2 Trials for Avelumab (DB11945)

IndicationStatusPhase
DBCOND0107096 (P16 Positive Squamous Cell Carcinoma of the Vagina or Vulva)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03357757Avelumab With Valproic Acid in Virus-associated CancerTreatment